Elanco Logo

Prevacent® PRRS

Prevacent logo

Prevacent® PRRS

Effective for the vaccination of healthy pigs 2 weeks of age or older against porcine reproductive and respiratory syndrome (PRRS); and against reproductive disease when vaccinated 6 weeks prior to breeding.

PRRS Control from the Start

  • Safe.
  • Smooth.
  • Effective.

PRRS Control from the Start

26 Week Immunity Against PRRS(1,2)

1 mL dose that is safe for all gestational stages3

93.2%

Reduced lung lesions4,5

Lineage 1

Contemporary & homologous

Pig Trial Summary


In a commercial study, Prevacent PRRS-vaccinated pigs showed no reduction in growth performance or difference in body weight at day 50 or day 125.6

Prevacent did not shed through the air during the 28-day sampling period.

Prevacent Growth Performance Graphic

In pigs, Prevacent caused less viremia than an MLV competitor on days 14 to 35 post-vaccination.7

Graph comparing viremia between Prevacent and Ingelvac vaccinated pigs

CT Value of Unvaccinated Controls at Time of Removal from Housing with Vaccinated Pigs7

Prevacent Mean CT Graph

Sow Trial Summary


Viremia: Total Positive8

Graph comparing viremia between Prevacent vaccinated sows and the control

Piglet Birth Weight8

Graph comparing piglet birth weights between Prevacent vaccinated sows and the control

Viremia Results for all Gilts8

Ad hoc statistical analysis of viremia results performed post-study completion. Treatment by day interaction: P < 0.0001; treatment effect: P = 0.0168 for all gilts.

Chart comparing viremia between Prevacent vaccinated sows and the control

Whole Herd PRRS Control

  • PRRS increases mortality and reduces growth performance of wean-to-finish pigs. PRRS may also cause an increase in the number of premature farrowings, late term abortions, stillborn piglets and mummified fetuses.9
  • With no reduction in growth performance or an impact on farrowing as a result of vaccination, Prevacent is a safe and effective solution for PRRS control across production segments.3,8

Prevacent logo

Prevacent Product Label

Read the full label for important use and safety information.

Download Label

Get Full Value from start to finish

Our portfolio offers solutions that manage disease challenges and mitigate mortality to optimize health.

Swine Respiratory Health

Respiratory Health

Managing both enteric and respiratory health challenges are critical to your herd's success.

See the Portfolio

The label contains complete use information, including cautions and warnings. Always read, follow and understand the label and use directions.


INDICATIONS:

  • This product has been shown to be effective for the vaccination of healthy pigs 2 weeks of age or older against PRRS respiratory disease; and against reproductive disease when vaccinated 6 weeks prior to breeding.
  • The duration of immunity against respiratory disease is at least 26 weeks.
  • The duration of immunity against reproductive disease has not been established. For more information regarding efficacy and safety data, go to productdata.aphis.usda.gov.
  • Safety of this product has been demonstrated when sows or gilts are vaccinated prior to breeding or at any stage of pregnancy.
  • Vaccine virus may be shed and transmitted to other populations of swine in contact with vaccinated swine.
  • The duration of potential vaccine virus transmission may vary.
  • Use of the vaccine in herds intended to remain PRRS virus seronegative is contraindicated.
  • Introduction of vaccinated pigs into herds intended to remain PRRS virus seronegative is contraindicated.

DOSAGE AND ADMINISTRATION:

  • Rehydrate with the accompanying sterile diluent.
  • Shake well and draw back into the syringe the required amount.
  • Administer 1 mL intramuscularly.
  • The need for annual booster vaccinations has not been established for this product; consultation with a veterinarian is recommended.

IMPORTANT SAFETY INFORMATION

PRECAUTIONS:

  • Store at 2°- 8°C (35°- 46°F). DO NOT FREEZE.
  • Use entire contents when first opened.
  • Do not mix with other products, except as specified on this label. In case of human exposure, contact a physician.
  • Do not vaccinate within 21 days before slaughter.
  • Inactivate unused contents before disposal.
  • Anaphylactic reactions may occur. Symptomatic treatment: Epinephrine.  Contains gentamicin as preservative.

About Elanco

Learn why we're a leading provider of innovative solutions that protect and enhance animal health.

Read About Elanco

Connect with Elanco

Elanco Logo
United StatesUnited States

PM-US-22-0866(2)

Elanco and the diagonal bar logo are trademarks of Elanco or its affiliates. ©2024 Elanco or its affiliates.